Mosquirix, generic name RTS,S/AS01 is the first malaria vaccine approved by the World Health Organisation on 6 October 2021. The vaccine is developed by a Brentford (UK) based pharmaceutical company GlaxoSmithKline, in partnership with an international nonprofit organisation PATH Malaria Vaccine ...